Literature DB >> 22499140

The fetal environment: a critical phase that determines future renal outcomes in autosomal dominant polycystic kidney disease.

Arlene B Chapman1.   

Abstract

Orskov and colleagues demonstrate the impact of birth weight on the mean age of end-stage renal disease (ESRD) in a large Danish ADPKD cohort. Each kilogram of birth weight extended the mean age of ESRD onset by 1.7 years. Placental insufficiency, activation of the renin-angiotensin-aldosterone system, increased fetal vasopressin levels, compensatory increases in insulin like growth factor-I, and a reduction in total nephron number may all contribute to this observation. Collectively, these changes result in an accelerated pace of cyst formation and expansion, and an inability to maintain glomerular hyperfiltration during kidney expansion which results in a more rapid progression to ESRD. Therefore the intrauterine environment may play a critical role in disease severity in ADPKD.

Entities:  

Mesh:

Year:  2012        PMID: 22499140      PMCID: PMC3489014          DOI: 10.1038/ki.2012.8

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Evidence of extraordinary growth in the progressive enlargement of renal cysts.

Authors:  Jared J Grantham; Larry T Cook; Louis H Wetzel; Melissa A Cadnapaphornchai; Kyongtae T Bae
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-01       Impact factor: 8.237

2.  Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; James E Bost; Vicente E Torres; Lisa Guay-Woodford; Kyongtae Ty Bae; Douglas Landsittel; Jie Li; Bernard F King; Diego Martin; Louis H Wetzel; Mark E Lockhart; Peter C Harris; Marva Moxey-Mims; Mike Flessner; William M Bennett; Jared J Grantham
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

Review 3.  The hyperfiltration theory: a paradigm shift in nephrology.

Authors:  B M Brenner; E V Lawler; H S Mackenzie
Journal:  Kidney Int       Date:  1996-06       Impact factor: 10.612

4.  Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease.

Authors:  Bjarne Orskov; Karl B Christensen; Bo Feldt-Rasmussen; Svend Strandgaard
Journal:  Kidney Int       Date:  2012-02-01       Impact factor: 10.612

5.  Volume progression in polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres; Arlene B Chapman; Lisa M Guay-Woodford; Kyongtae T Bae; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Phillip J Kenney; Peter C Harris; Saulo Klahr; William M Bennett; Gladys N Hirschman; Catherine M Meyers; Xiaoling Zhang; Fang Zhu; John P Miller
Journal:  N Engl J Med       Date:  2006-05-18       Impact factor: 91.245

6.  A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease.

Authors:  W E Hoy; M Rees; E Kile; J D Mathews; Z Wang
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

7.  Renal injury is a third hit promoting rapid development of adult polycystic kidney disease.

Authors:  Ayumi Takakura; Leah Contrino; Xiangzhi Zhou; Joseph V Bonventre; Yanping Sun; Benjamin D Humphreys; Jing Zhou
Journal:  Hum Mol Genet       Date:  2009-04-02       Impact factor: 6.150

Review 8.  Adaptive responses of the maternal hypothalamic-pituitary-adrenal axis during pregnancy and lactation.

Authors:  P J Brunton; J A Russell; A J Douglas
Journal:  J Neuroendocrinol       Date:  2008-06       Impact factor: 3.627

Review 9.  Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.

Authors:  Jared J Grantham; Arlene B Chapman; Vicente E Torres
Journal:  Clin J Am Soc Nephrol       Date:  2005-10-19       Impact factor: 8.237

10.  Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study.

Authors:  Andreas L Serra; Andreas D Kistler; Diane Poster; Marian Struker; Rudolf P Wüthrich; Dominik Weishaupt; Frank Tschirch
Journal:  BMC Nephrol       Date:  2007-09-15       Impact factor: 2.388

View more
  5 in total

Review 1.  Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?

Authors:  Peter Janssens; Caroline Weydert; Stephanie De Rechter; Karl Martin Wissing; Max Christoph Liebau; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2017-04-28       Impact factor: 3.714

2.  Generation of heterozygous PKD1 mutant pigs exhibiting early-onset renal cyst formation.

Authors:  Masahito Watanabe; Kazuhiro Umeyama; Kazuaki Nakano; Hitomi Matsunari; Toru Fukuda; Kei Matsumoto; Susumu Tajiri; Shuichiro Yamanaka; Koki Hasegawa; Kazutoshi Okamoto; Ayuko Uchikura; Shuko Takayanagi; Masaki Nagaya; Takashi Yokoo; Hiromitsu Nakauchi; Hiroshi Nagashima
Journal:  Lab Invest       Date:  2022-01-03       Impact factor: 5.502

Review 3.  Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Res       Date:  2013-10-31       Impact factor: 3.756

4.  Prenatal famine exposure and estimated glomerular filtration rate across consecutive generations: association and epigenetic mediation in a population-based cohort study in Suihua China.

Authors:  Wenbo Jiang; Tianshu Han; Wei Duan; Qiuying Dong; Wanying Hou; Huanyu Wu; Yue Wang; Zehui Jiang; Xinyi Pei; Yingying Chen; Ying Li; Changhao Sun
Journal:  Aging (Albany NY)       Date:  2020-06-18       Impact factor: 5.682

5.  Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease.

Authors:  William E Sweeney; Philip Frost; Ellis D Avner
Journal:  World J Nephrol       Date:  2017-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.